Navigation Links
Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
Date:7/29/2008

s adverse events reported with PBT2.

"These results indicate that PBT2 is having an impact on the underlying biology of Alzheimer's, which is very exciting," Cummings said. "This is a critical proof of concept, and the safety and efficacy demonstrated by PBT2 in this study warrant evaluation in larger scale clinical trials in Alzheimer's."

A Phase IIb trial of a Tau Aggregation Inhibitor Therapy

As an alternative to anti-amyloid therapies for Alzheimer's, researchers continue to examine a variety of treatments and targets with the potential to curb the disease. This includes presenting data supporting the viability of therapies targeting tau protein and its aggregation into the "tangles" originally discovered by Alois Alzheimer.

Previous research has shown that the buildup of brain lesions known as neurofibrillary tangles, which are composed of a short fragment of a protein called tau, is correlated with increasing levels of dementia symptoms. And, these tangles first appear in the brain long before symptoms of the disease become clinically apparent. Methylthioninium chloride (MTC, or brand name rember(TM)) has been shown in the test tube to dissolve tau tangle filaments and prevent aggregation of tau into tangles. MTC has also been shown to block the toxic effects of aggregated tau in cells. In animal models, MTC has demonstrated cognitive and behavioral benefits in line with reduced tau pathology.

In research reported at ICAD 2008, Claude M. Wischik, Professor in Mental Health, University of Aberdeen, United Kingdom and Chairman, TauRx Therapeutics, Singapore, and colleagues conducted a 24-week, double-blind, randomized, dose-ranging, parallel design trial of MTC monotherapy in 321 people with Alzheimer's at 17 centers in the United Kingdom and Singapore, followed by a 60-week, blinded, active treatment extension. The control group received placebo for the initial 24 weeks and then a minimal efficacy dose subsequently. The primar
'/>"/>

SOURCE Alzheimer's Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
2. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
5. Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
6. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
7. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
8. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
9. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
10. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
11. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... /PRNewswire/--  Apexigen, Inc. , a biopharmaceutical company ... of cancer and other life-threatening diseases, announced today it ... at the Cavendish Global Health Impact Forum taking place ... in La Jolla, California . The ... and foundations develop and implement their individual pro-social impact ...
(Date:5/6/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... and device innovation center in Cambridge, Massachusetts ... attract top scientists and bioengineers, as well as enhance ... Lilly Cambridge Innovation Center, a makerspace located in Kendall ... to explore how emerging technologies and connectivity can advance ...
(Date:5/6/2015)... GERMANTOWN, Md. , May 6, 2015 ... neural stem cell technology to develop small molecule and ... the appointment of Jonathan Lloyd Jones to ... th . Mr. Lloyd Jones ... of corporate finance and business development experience.   Most recently, ...
Breaking Medicine Technology:Apexigen Selected to Present at Cavendish Global Health Impact Forum 2Apexigen Selected to Present at Cavendish Global Health Impact Forum 3Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4
(Date:5/6/2015)... Los Angeles (PRWEB) May 06, 2015 ... WaterAid, the #1 ranked international water, sanitation and hygiene ... work for communities across the world and it brings ... Lindsey Carnett, CEO of Marketing Maven. “The ongoing relationship ... the opportunities available for people to learn about and ...
(Date:5/6/2015)... Texas (PRWEB) May 06, 2015 vcfo, ... finance, HR, IT and operational support to optimize business ... Consulting CFOs, Jack Lynch and Michael Scheaffer. Both Lynch ... finance and leadership experience. , “We are delighted ... Ellen Wood, vcfo CEO. “Leveraging their background in financial ...
(Date:5/6/2015)... Follow us on LinkedIn – ... the rising consumer awareness over the importance of hand ... washing is becoming a part of personal hygiene practices ... Periodic outbreak of Avian flu, Swine flu, and SARS, ... (EVD) epidemic in West Africa are mega force ...
(Date:5/6/2015)... In March, Dr. Rami K. Batniji had ... As Europe’s most exclusive rhinoplasty conference, the attendees include some ... was hand chosen to speak by the President of the ... Palma. , The Milano Masterclass is held every ... diverse, multi-national faculty; each considered a rhinoplasty expert in their ...
(Date:5/6/2015)... 2015 The 2015 STEMtech conference exhibition ... Partner booth selection . Don’t miss this opportunity ... college and university decision-makers from around the country. , ... at the Arizona Grand in Phoenix. This beautiful all-suite ... the doorstep of the South Mountain Preserve. The Phoenix ...
Breaking Medicine News(10 mins):Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 4Health News:California Surgeon Speaks at International Rhinoplasty Conference 2Health News:STEMtech Conference Exhibitors Gain Access to Community College and University Representatives From Across the U.S. 2
... major child birth charity has urged midwives and hospitals in ... According to the charity, labour and birth in water offers ... with an uncomplicated pregnancy at term. Past research has also ... control and relaxed, resulting in less painful contractions, less stress// ...
... led by Glenn Dranoff, MD,have reported in the February ... made from patients' own tumors are safe and future ... deadly cancers. Researchers claim that the tumors grow out ... system attacks -- ignore them. In the new study ...
... DCM is a condition which occurs when the heart becomes ... blood efficiently. The condition affects 35 in every 100,000 people. ... study published in the journal Science that a defect in ... key role in regulating the flow of calcium through the ...
... New England Journal of Medicine has challenged the American ... (angiotensin-converting enzyme) inhibitors and calcium channel blockers in controlling ... were mostly white. Blood pressure reduction was the same ... took an ACE inhibitor. The incidence of stroke was ...
... the British Medical Journal has reported that women who had ... later in life than those who had not. 129,290 women, ... years 1981-85, were identified as eligible for the study. Nearly ... 1981 to 1999, the researchers used hospital discharge and death ...
... our cells, which could lead to cancer. However, researchers ... mechanism in the body, which both repairs the damage ... molecule called MDC1, which initiates this protection mechanism, was ... Developmental// Biology, Cambridge. MDC1 is believed to play a ...
Cached Medicine News:Health News:New lung cancer vaccine on the anvil 2Health News:Miscarriage during pregnancy and heart disease linked 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: